Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Insurance topic
No spam. Unsubscribe anytime.
Committee approves bill requiring insurers to cover GLP‑1 drugs, removes Medicaid trigger
Summary
The committee adopted Representative Aaron Pilkington’s amendment that rewrote HB1332: Medicaid coverage was removed, DHS will track obesity-related medication use and costs, and private insurers must cover GLP‑1 medications while retaining discretion to set authorization standards. The committee passed the bill as amended by voice vote.
The House Public Health, Welfare and Labor Committee adopted an amendment that rewrote House Bill 1332 and then voted to pass the measure as amended.
Representative Aaron Pilkington (R‑District 45) told the committee the amendment removes Medicaid from the bill and instead requires the Department of Human Services to track obesity‑related medication use and associated costs. The amendment also requires private insurers to cover GLP‑1 class medications but allows insurers to set authorization criteria and clinical guardrails for coverage.
Pilkington said the rewrite came after federal guidance changes and stakeholder discussions. “We completely took Medicaid out of it,” he told the committee; the amended bill was “the bill now,” he said after adoption of the amendment.
Representative Allen and other members asked clarifying questions; Pilkington confirmed the measure applies to private insurers and that insurers may set clinical authorization standards to prevent inappropriate prescribing. The motion to adopt the amendment and the subsequent motion to pass the bill carried by voice vote.
The bill as amended directs DHS to monitor utilization and costs for obesity‑related care to inform future policy decisions; it does not create an immediate Medicaid coverage mandate.
No roll-call tally was recorded in the transcript; the committee chair announced passage on a voice vote.
